Agen C - Search Results

1

Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.

Innocenti F, Danesi R, Di Paolo A, Agen C, Nardini D, Bocci G, Del Tacca M. Innocenti F, et al. Among authors: agen c. Drug Metab Dispos. 1995 Jul;23(7):713-7. Drug Metab Dispos. 1995. PMID: 7587959

2

Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines.

di Paolo A, Bocci G, Innocenti F, Agen C, Nardini D, Danesi R, del Tacca M. di Paolo A, et al. Among authors: agen c. Pharmacol Res. 1995 Sep;32(3):135-9. doi: 10.1016/s1043-6618(05)80006-4. Pharmacol Res. 1995. PMID: 8745343

3

Atrial natriuretic peptide inhibits the spontaneous contractions of rabbit isolated ileum.

Blandizzi C, Agen C, Natale G, Del Tacca M. Blandizzi C, et al. Among authors: agen c. J Pharm Pharmacol. 1992 Jul;44(7):615-7. doi: 10.1111/j.2042-7158.1992.tb05477.x. J Pharm Pharmacol. 1992. PMID: 1357147

4

Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart.

Agen C, Sironi AM, Danesi R, Costa M, Bernardini N, Paparelli A, Della Torre P, Del Tacca M. Agen C, et al. Toxicology. 1992 Nov 15;75(3):209-19. doi: 10.1016/0300-483x(92)90003-w. Toxicology. 1992. PMID: 1455430

5

Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Bernardini N, Agen C, Favilla S, Danesi R, Del Tacca M. Bernardini N, et al. Among authors: agen c. J Endocrinol Invest. 1992 Feb;15(2):79-84. doi: 10.1007/BF03348668. J Endocrinol Invest. 1992. PMID: 1533234

6

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.

Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601

7

MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery.

Costa M, Danesi R, Agen C, Di Paolo A, Basolo F, Del Bianchi S, Del Tacca M. Costa M, et al. Among authors: agen c. Cancer Res. 1994 Jan 1;54(1):9-11. Cancer Res. 1994. PMID: 7505201

8

Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.

Pinna A, Agen C, Di Paolo A, Innocenti F, Nardini D, Danesi R, Del Tacca M. Pinna A, et al. Among authors: agen c. J Environ Pathol Toxicol Oncol. 1994;13(1):25-31. J Environ Pathol Toxicol Oncol. 1994. PMID: 7823290

9

3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity.

Danesi R, Agen C, Grandi M, Nardini V, Bevilacqua G, Del Tacca M. Danesi R, et al. Among authors: agen c. Eur J Cancer. 1993;29A(11):1560-5. doi: 10.1016/0959-8049(93)90295-q. Eur J Cancer. 1993. PMID: 8217363

10

Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Zaccaro L, Pieracci D, Malvaldi G, Del Tacca M. Danesi R, et al. Among authors: agen c. Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942. Cancer Chemother Pharmacol. 1992. PMID: 1472260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters